US approval of Gilead’s six-month HIV preventive injection, Yeztugo (lenacapavir), marks a significant advance in the global struggle against HIV–Aids. Two injections a year to provide near-total protection from infection is a huge step up…
US approval of Gilead’s six-month HIV preventive injection, Yeztugo (lenacapavir), marks a significant advance in the global struggle against HIV–Aids. Two injections a year to provide near-total protection from infection is a huge step up…